Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 25

Sort by

Sort Order Select

Journal Articles

Genetic characterization of B-cell prolymphocytic leukemia: a prognostic model involving MYC and TP53

Blood (2019) 134 (21): 1821–1831.

https://doi.org/10.1182/blood.2019001187

Published: 2019

Includes: Supplemental data

Journal Articles

Prognostic Value of Immunohistochemical Markers in Stage III/IV Classical Hodgkin Lymphoma Treated Frontline in the Lysa EORTC 20012 Randomized Protocol

Danielle Canioni, MD, Pauline Brice, MD, Serge Bologna, MD, Laurent Voillat, MD, Jean Gabarre, MD, Olivier Casasnovas, MD, Alain Devidas, MD, Bertrand Coiffier, MD PhD, Malek Aoudjhane, MD, Bruno Audhuy, MD, Marc Andre, MD, Catherine Fortpied, MD, Patrice Carde, MD PhD, Nicolas Mounier, MD, Josette Briere, MD

Blood (2018) 132 (Supplement 1): 4132.

https://doi.org/10.1182/blood-2018-99-118039

Published: 2018

Journal Articles

Clonal Evolution in CLL

Simon Bouzy, Marine Armand, Clementine Gabillaud, Elise Chapiro, Nadia Bougacha, Fotini Kostopoulou, PhD, Frederic Davi, MD PhD, Magali Le Garff-Tavernier, Karim Maloum, Veronique Leblond, Veronique Morel, Damien Roos-Weil, Anne Lavaud, Jean Gabarre, Choquet Sylvain, Santos Susin, Olivier Bernard, Florence Nguyen-Khac, MD PhD

Blood (2017) 130 (Supplement 1): 3008.

https://doi.org/10.1182/blood.V130.Suppl_1.3008.3008

Published: 2017

Journal Articles

The Gain of the Short Arm of Chromosome 2 (2pgain) Plays an Important Role in CLL Drug Resistance, and Has to be Systematically Considered before Deciding an Adapted Therapy

Fotini Kostopoulou, PhD, Nadia Bougacha, Clementine Gabillaud, Elise Chapiro, Simon Bouzy, Magali Le Garff-Tavernier, Pharm, PhD, Karim Maloum, Choquet Sylvain, Veronique Leblond, Jean Gabarre, Anne Lavaud, Veronique Morel, Damien Roos-Weil, Madalina Uzunov, Romain Guieze, MD PhD, Olivier Tournilhac, MD PhD, Santos Susin, Olivier Bernard, Florence Nguyen-Khac, MD PhD

Blood (2017) 130 (Supplement 1): 1729.

https://doi.org/10.1182/blood.V130.Suppl_1.1729.1729

Published: 2017

Journal Articles

Coinfection with HCV or HBV Increases the Risk of Lymphoma in HIV-Positive Patients: A Combined Analysis of the Lymphovir-ANRS-CO16 and Fhdh-ANRS-CO4 Cohorts

Blood (2017) 130 (Supplement 1): 1003.

https://doi.org/10.1182/blood.V130.Suppl_1.1003.1003

Published: 2017

Journal Articles

Characteristics and Outcome of HIV Associated Classical Hodgkin's Lymphoma Among 68 Patients Included in the French ANRS CO16 Lymphovir Cohort Study

Blood (2014) 124 (21): 2954.

https://doi.org/10.1182/blood.V124.21.2954.2954

Published: 2014

Journal Articles

Pre-Phase Chemotherapy Followed By Ofatumumab (OFA) and Reduced Dose CHOP (OFA-mini-CHOP) for Patients over 80 Years with Diffuse Large B-Cell Lymphoma (DLBCL) – a Lymphoma Study Association (LYSA) Prospective Phase II Study (LNH09-7B)

Blood (2014) 124 (21): 3042.

https://doi.org/10.1182/blood.V124.21.3042.3042

Published: 2014

Journal Articles

Lenalidomide In Combination With R-CHOP (R2-CHOP) In Patients With High Burden Follicular Lymphoma: Phase 2 Study

Herve Tilly, MD, Franck Morschhauser, MD, PhD, Olivier Casasnovas, MD, Thierry Jo Molina, MD, PhD, Nicolas Mounier, MD, PhD, Gilles Andre Salles, MD, PhD, Steven Le Gouill, MD, PhD, Serge Bologna, MD, Olivier Tournilhac, MD, PhD, Jose Cabecadas, MD, Reda Bouabdallah, MD, Jean Gabarre, MD, Thierry Lamy, MD, PhD, Corinne Haioun, MD, PhD

Blood (2013) 122 (21): 248.

https://doi.org/10.1182/blood.V122.21.248.248

Published: 2013

Journal Articles

Characteristics and Outcome Among 116 Patients with HIV Associated Lymphoma Included in the French ANRS CO16 Lymphovir Cohort Study.

Caroline Besson, Sophie Prevot, Houria Chavez, Selma Trabelsi, Michele Genin, Patricia Rince, Marie-Caroline Meyohas, Bruno Marchou, Jean Gabarre, Fabrice Bonnet, Cecile Goujard, Francois Boue, MD, PhD, Francois Raffi, Maria Partisani, Nicolas Mounier, MD, PhD, Yassine Taoufik, Martine Raphael, MD, PhD, Dominique Costagliola

Blood (2012) 120 (21): 2147.

https://doi.org/10.1182/blood.V120.21.2147.2147

Published: 2012

Journal Articles

Result of FDG PET-CT Imaging After Immunochemotherapy Induction Is a Powerful and Independent Prognostic Indicator of Outcome for Patients with Follicular Lymphoma: An Analysis From the PRIMA Study

Judith Trotman, MBChB, FRACP, FRCPA, Marion Fournier, Thierry Lamy, MD, PhD, Jane A Estell, MBBS, FRCPA, FRACP, Anne Sonet, MD, Andrea Janikova, MD, PhD, Herve Tilly, Didier Decaudin, Jean Gabarre, MD, John F Seymour, MD, FRACP, Etienne Garin, Cecily Forsyth, Michael Fulham, MBBS, FRACP, Thierry Vander Borght, MD, PhD, Ofer Shpilberg, MD, MPH, Gilles Salles

Blood (2010) 116 (21): 855.

https://doi.org/10.1182/blood.V116.21.855.855

Published: 2010

Journal Articles

Prognostic Factors and Long Term Outcome of 138 Adults with Systemic Anaplastic Large-Cell Lymphoma: a Retrospective Study by the Groupe d'Etude Des Lymphomes De l'Adulte (GELA)

David Sibon, MD, PhD, Marion Fournier, Josette Briere, MD, Laurence Lamant, MD, PhD, Corinne Haioun, MD, Bertrand Coiffier, MD, PhD, Serge Bologna, MD, Pierre Morel, MD, Jean Gabarre, MD, Olivier Hermine, MD, PhD, Anne Sonet, MD, Christian Gisselbrecht, MD, Georges Delsol, MD, Philippe Gaulard, MD, Herve Tilly, MD

Blood (2010) 116 (21): 322.

https://doi.org/10.1182/blood.V116.21.322.322

Published: 2010

Journal Articles

Long Term Results of Stanford V Regimen and Highly Active Antiretroviral Therapy (HAART) In 59 Patients (pts) with HD and HIV Infection (HD-HIV)

Michele Spina, MD, Jean Gabarre, MD, Salvatrice Mancuso, Alessandro Re, Clara Schiantarelli, Renato Talamini, Emanuela Vaccher, Umberto Tirelli

Blood (2010) 116 (21): 4827.

https://doi.org/10.1182/blood.V116.21.4827.4827

Published: 2010

Journal Articles

Hodgkin's Disease and HIV Infection (HD-HIV): Prognostic Factors In 596 Patients (pts) within the European Group for the Study of HIV and Tumours (GECAT)

Michele Spina, MD, Josep-Maria Ribera, MD, PhD, Jean Gabarre, MD, Christoph Wyen, Silvia Montoto, MD, Ulrich Jaeger, MD, Renato Talamini, Alessandro Re, Pilar Miralles, Umberto Tirelli

Blood (2010) 116 (21): 3883.

https://doi.org/10.1182/blood.V116.21.3883.3883

Published: 2010

Journal Articles

A Prospective Randomized Study Comparing Dose Intensive Immunochemotherapy with R-ACVBP vs Standard R-CHOP In Younger Patients with Diffuse Large B-Cell Lymphoma (DLBCL). Groupe d'Etude Des Lymphomes De l'Adulte (GELA) Study LNH03-2B

Blood (2010) 116 (21): 109.

https://doi.org/10.1182/blood.V116.21.109.109

Published: 2010

Journal Articles

Pharmacogenetic study in Hodgkin lymphomas reveals the impact of UGT1A1 polymorphisms on patient prognosis

Vincent Ribrag, Serge Koscielny, Olivier Casasnovas, Cecile Cazeneuve, Pauline Brice, Franck Morschhauser, Jean Gabarre, Aspasia Stamatoullas, Gilbert Lenoir, Gilles Salles

Blood (2009) 113 (14): 3307–3313.

https://doi.org/10.1182/blood-2008-03-148874

Published: 2009

Journal Articles

A Multicenter Study of a Gemcitabine-Based Regimen in Relapsed or Refractory Hodgkin’s Lymphoma Patients.

Patricia Validire, MD, Christophe Fermé, MD, Pauline Brice, MD, Marine Diviné, MD, Jean Gabarre, MD, Krimo Bouabdallah, MD, Olivier Fitoussi, MD, Driss Chaoui, MD, Hélène Pacquement, MD, Carole Soussain, MD, Patrice Carde, MD, Rafika Sahli, MD, Didier Decaudin, MD, PhD

Blood (2007) 110 (11): 4436.

https://doi.org/10.1182/blood.V110.11.4436.4436

Published: 2007

Journal Articles

Pharmacogenetic Study in Hodgkin’s Lymphomas, Impact of UGT1A1 on Prognosis.

Vincent Ribrag, MD, Serge Koscielny, phD, Olivier Casasnovas, MD, Cecile Cazeneuve, MD, phD, Pauline Brice, MD, Franck Morschhauser, MD, Jean Gabarre, MD, Marine Divine, MD, Laurent Voillat, MD, Apasia Stamatoullas, MD, Gilbert Lenoir, phD, Gilles Andre Salles, MD, phD

Blood (2006) 108 (11): 2266.

https://doi.org/10.1182/blood.V108.11.2266.2266

Published: 2006

Journal Articles

AIDS-related non-Hodgkin lymphoma: final analysis of 485 patients treated with risk-adapted intensive chemotherapy

Nicolas Mounier, Michele Spina, Jean Gabarre, Martine Raphael, Giuliano Rizzardini, Jean-Baptiste Golfier, Emanuela Vaccher, Antonino Carbone, Bertrand Coiffier, Guido Chichino, Andre Bosly, Umberto Tirelli, Christian Gisselbrecht, for the French-Italian cooperative group

Blood (2006) 107 (10): 3832–3840.

https://doi.org/10.1182/blood-2005-09-3600

Published: 2006

Journal Articles

Rituximab vs Observation after High-Dose Consolidative First-Line Chemotherapy (HDC) with Autologous Stem Cell Transplantation in Poor Risk Diffuse Large B-Cell Lymphoma. Final Analysis of the LNH98-B3 GELA Study.

Corinne Haioun, Nicolas Mounier, Jean François Emile, Pierre Feugier, Bertrand Coiffier, Hervé Tilly, Christian Recher, Christophe Fermé, Jean Gabarre, Raoul Herbrecht, Frank Morschhauser12, Christian Gisselbrecht

Blood (2005) 106 (11): 677.

https://doi.org/10.1182/blood.V106.11.677.677

Published: 2005

Journal Articles

Four ABVD and Involved-Field Radiotherapy in Unfavorable Supradiaphragmatic Clinical Stages (CS) I-II Hodgkin’s Lymphoma (HL): Preliminary Results of the EORTC-GELA H9-U Trial.

Christophe Ferme, MD, Marine Diviné, MD, Andrej Vranovsky, MD, Frank Morschhauser, MD, Réda Bouabdallah, MD, Jean Gabarre, MD, Aspasia Bastard-Stamatoullas, MD, Richard Delarue, MD, Vittorina Zagonel, MD, Jérôme Jaubert, MD, Anton Hagenbeek, MD, Mark Henri H. Kramer, MD, Chantal Rieux, José Thomas, MD, Michel Henry-Amar, MD

Blood (2005) 106 (11): 813.

https://doi.org/10.1182/blood.V106.11.813.813

Published: 2005

NARROW

Genetic characterization of B-cell prolymphocytic leukemia: a prognostic model involving MYC and TP53

Prognostic Value of Immunohistochemical Markers in Stage III/IV Classical Hodgkin Lymphoma Treated Frontline in the Lysa EORTC 20012 Randomized Protocol

Clonal Evolution in CLL

The Gain of the Short Arm of Chromosome 2 (2pgain) Plays an Important Role in CLL Drug Resistance, and Has to be Systematically Considered before Deciding an Adapted Therapy

Coinfection with HCV or HBV Increases the Risk of Lymphoma in HIV-Positive Patients: A Combined Analysis of the Lymphovir-ANRS-CO16 and Fhdh-ANRS-CO4 Cohorts

Characteristics and Outcome of HIV Associated Classical Hodgkin's Lymphoma Among 68 Patients Included in the French ANRS CO16 Lymphovir Cohort Study

Pre-Phase Chemotherapy Followed By Ofatumumab (OFA) and Reduced Dose CHOP (OFA-mini-CHOP) for Patients over 80 Years with Diffuse Large B-Cell Lymphoma (DLBCL) – a Lymphoma Study Association (LYSA) Prospective Phase II Study (LNH09-7B)

Lenalidomide In Combination With R-CHOP (R2-CHOP) In Patients With High Burden Follicular Lymphoma: Phase 2 Study

Characteristics and Outcome Among 116 Patients with HIV Associated Lymphoma Included in the French ANRS CO16 Lymphovir Cohort Study.

Result of FDG PET-CT Imaging After Immunochemotherapy Induction Is a Powerful and Independent Prognostic Indicator of Outcome for Patients with Follicular Lymphoma: An Analysis From the PRIMA Study

Prognostic Factors and Long Term Outcome of 138 Adults with Systemic Anaplastic Large-Cell Lymphoma: a Retrospective Study by the Groupe d'Etude Des Lymphomes De l'Adulte (GELA)

Long Term Results of Stanford V Regimen and Highly Active Antiretroviral Therapy (HAART) In 59 Patients (pts) with HD and HIV Infection (HD-HIV)

Hodgkin's Disease and HIV Infection (HD-HIV): Prognostic Factors In 596 Patients (pts) within the European Group for the Study of HIV and Tumours (GECAT)

A Prospective Randomized Study Comparing Dose Intensive Immunochemotherapy with R-ACVBP vs Standard R-CHOP In Younger Patients with Diffuse Large B-Cell Lymphoma (DLBCL). Groupe d'Etude Des Lymphomes De l'Adulte (GELA) Study LNH03-2B

Pharmacogenetic study in Hodgkin lymphomas reveals the impact of UGT1A1 polymorphisms on patient prognosis

A Multicenter Study of a Gemcitabine-Based Regimen in Relapsed or Refractory Hodgkin’s Lymphoma Patients.

Pharmacogenetic Study in Hodgkin’s Lymphomas, Impact of UGT1A1 on Prognosis.

AIDS-related non-Hodgkin lymphoma: final analysis of 485 patients treated with risk-adapted intensive chemotherapy

Rituximab vs Observation after High-Dose Consolidative First-Line Chemotherapy (HDC) with Autologous Stem Cell Transplantation in Poor Risk Diffuse Large B-Cell Lymphoma. Final Analysis of the LNH98-B3 GELA Study.

Four ABVD and Involved-Field Radiotherapy in Unfavorable Supradiaphragmatic Clinical Stages (CS) I-II Hodgkin’s Lymphoma (HL): Preliminary Results of the EORTC-GELA H9-U Trial.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only